An interventional study of Suprainguinal Fascia Iliaca Block and Quadro-Iliac Plane Block in Post Operative Pain, sponsored by Hitit University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-04.
Sponsored by Hitit University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Pain, Postoperative by Hitit University — 4 open to participants now, 4 under way, none of them phase 3. Pain, Postoperative · Hitit University.
Among the 10 studies in Pain, Postoperative by Hitit University, this one is the 2nd largest by enrollment, is one of 4 that started in 2026, is one of 10 with no phase, and was the 5th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →4 of the 10 studies in Pain, Postoperative by Hitit University are open now, in 1 country. Recruiting first, the newest first:
Hitit University · Sites in Turkey
Ages 18–75
Hitit University · Sites in Turkey
Ages 18–80
Hitit University · Sites in Turkey
Ages 18–80
Hitit University
Ages 18–65 · Women only
By country, each count listing its studies:
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2022; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 85 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 74 across the 10 interventional studies. Of the 6 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Hitit University is the lead sponsor of 87 studies on the registry; 28 are open to participants now.
3 of the studies in Pain, Postoperative by Hitit University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07695935Hitit UniversityTransversalis Fascia Plane Block Versus Low-Dose Intrathecal Morphine for Open Inguinal Hernia Repair | 2026-12-01 |
| NCT07721571Hitit UniversityNephrostomy Tract Infiltration for Pain Control After PCNL | 2027-01-11 |
| NCT07899190Hitit UniversityCOMPARISON OF THE POSTOPERATIVE ANALGESIC EFFECTS OF ULTRASOUND-GUIDED QUADRO-ILIAC PLANE AND TRANSVERSUS ABDOMINIS PLANE BLOCKS IN PATIENTS UNDERGOING TOTAL LAPAROSCOPIC HYSTERECTOMY | 2027-06 |
Add all 3 to your calendar (.ics) → With an account.
Among the 10 studies in Pain, Postoperative by Hitit University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective, randomized, double-masked trial compared two ultrasound-guided regional analgesic techniques, suprainguinal fascia iliaca block (SIFI) and quadro-iliac plane block (QIPB), in adults undergoing surgery for hip fracture under spinal anesthesia. The primary outcome was total opioid consumption, expressed as approximate intravenous morphine equivalents, during the first 24 hours after complete resolution of spinal motor block (Bromage score 0). Secondary outcomes included pain at rest and during movement assessed using a 0-10 numeric rating scale, rescue analgesic requirements, nausea and vomiting, quality of recovery, time to first assisted standing and other recovery measures, and patient satisfaction. Both groups received the same postoperative multimodal analgesic regimen. Eighty-five participants were randomized, and 70 participants completed follow-up and were included in the reported analysis.
This prospective, parallel-group randomized trial compared two ultrasound-guided blocks in adults undergoing hip fracture surgery under spinal anesthesia. Participants and postoperative outcome assessors were masked; the anesthesiologist performing the block knew the assigned technique. Eighty-five participants were randomized (43 SIFI and 42 QIPB), and 35 per group were included in the reported analysis after post-randomization exclusions. Different surgical procedures for hip fracture were included; procedure type was not used for subgroup analysis.
Both blocks were performed before spinal anesthesia using a linear ultrasound probe and an 80-mm peripheral block needle. SIFI was performed supine, with injection deep to fascia iliaca over the iliacus muscle and suprainguinal spread. QIPB targeted the fascial plane related to the posterior surface of quadratus lumborum at its attachment to the iliac crest. QIPB was performed prone, or in lateral decubitus when pain prevented tolerance of prone positioning. Both blocks used 40 mL of 0.25% bupivacaine (100 mg). The peripheral block dose limit was 2 mg/kg; no dose reduction was required. Spinal anesthesia used 12.5 mg of 0.5% hyperbaric bupivacaine.
Both groups received intravenous paracetamol 1 g every eight hours and tramadol patient-controlled analgesia (10-mg bolus, 20-minute lockout, no background infusion, maximum 400 mg per day). Rescue analgesia was 25 micrograms of intravenous fentanyl if either rest or movement pain exceeded 4 on the numeric rating scale. Rescue doses were recorded separately from patient-controlled analgesia button presses. Pain was reassessed at the next scheduled assessment, with further rescue analgesia when required.
Time zero was complete resolution of spinal motor block (Bromage score 0). Rest and movement pain were assessed at 0, 1, 3, 6, 12, 18 and 24 hours from time zero. Movement was defined as changing from a lying to a sitting position. Opioid consumption and rescue analgesia were assessed within the same 24-hour window. Tramadol and fentanyl doses were recorded separately and summarized as approximate intravenous morphine equivalents. The Turkish QoR-15 was administered before surgery and 24 hours after time zero; higher scores indicate better recovery. First assisted standing, first oral intake and first passage of either flatus or stool were timed from time zero. Satisfaction was rated from 1 to 10.
The first participant was enrolled on May 4, 2026. Final primary outcome assessments and all study follow-up were completed on September 13, 2026.
The difference in outcome priority between the protocol and the initial registry version was reconciled after study completion by adopting the protocol hierarchy.
The criteria were revised on the registry on Oct 30, 2026. See what changed
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Criteria for withdrawal after enrollment:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before spinal anesthesia, participants received ultrasound-guided suprainguinal fascia iliaca block in the supine position. A sterile-covered linear probe and an 80-mm peripheral block needle were used. The needle was advanced in-plane to the space deep to fascia iliaca and superficial to iliacus, proximal to the inguinal ligament. After hydrodissection with 2 mL saline, 40 mL of 0.25% bupivacaine (100 mg) was injected while observing spread in the fascial plane. Both groups received the same spinal anesthesia and postoperative multimodal analgesic regimen.
Procedure: Suprainguinal Fascia Iliaca Block
Before spinal anesthesia, participants received ultrasound-guided quadro-iliac plane block. The patient was prone, or in lateral decubitus when pain prevented tolerance of the prone position. A sterile-covered linear probe and an 80-mm peripheral block needle were used. Ultrasound orientation identified quadratus lumborum and its attachment to the iliac crest. The needle targeted the fascial plane related to the posterior surface of quadratus lumborum at this level. After hydrodissection, 40 mL of 0.25% bupivacaine (100 mg) was injected with ultrasound observation of fascial plane spread. Both groups received the same spinal anesthesia and postoperative multimodal analgesic regimen.
Procedure: Quadro-Iliac Plane Block
the area between the iliacus muscle and the fascia iliaca will be reached at the level of the anterior superior iliac spine, proximal to the inguinal ligament. Hydrodissection will be performed with 2 mL of saline, followed by the injection of 40 mL of 0.25% bupivacaine.
Ultrasound-guided injection of 40 mL 0.25% bupivacaine (100 mg) into the fascial plane related to the posterior surface of quadratus lumborum at its attachment to the iliac crest, before spinal anesthesia. A linear probe and an 80-mm peripheral block needle were used. Patients were prone or, when pain prevented tolerance of prone positioning, in lateral decubitus.
Total opioid consumption during the first 24 hours after Bromage score 0
Total tramadol delivered by intravenous patient-controlled analgesia and intravenous fentanyl administered as rescue analgesia were recorded separately. Approximate intravenous morphine equivalents (mg) were calculated as 0.1 × tramadol (mg) + fentanyl (micrograms)/15. Premedication fentanyl was excluded.
Time frame: First 24 hours after complete resolution of spinal motor block (Bromage score 0)
Pain at rest and during movement assessed by the Numeric Rating Scale (NRS)
Rest and movement pain were assessed separately using an 11-point numeric rating scale: 0 indicates no pain and 10 the worst imaginable pain. Movement was defined as changing from a lying to a sitting position. Time zero was complete resolution of spinal motor block (Bromage score 0). Both pain series during the first 24 hours were secondary outcomes.
Time frame: 0, 1, 3, 6, 12, 18 and 24 hours after complete resolution of spinal motor block (Bromage score 0)
Rescue analgesia requirement
Number of participants receiving at least one rescue analgesic dose. Rescue analgesia was 25 micrograms intravenous fentanyl when either rest or movement NRS exceeded 4. Patient-controlled analgesia button presses were not classified as rescue analgesia.
Time frame: First 24 hours after Bromage score 0
Time to first rescue analgesia
Time in minutes from Bromage score 0 to the first intravenous rescue fentanyl administration. Participants without rescue analgesia were censored at 24 hours for time-to-event analysis.
Time frame: Up to 24 hours after Bromage score 0
Postoperative nausea and vomiting
Nausea and vomiting were scored at each assessment on the study scale: 1, no nausea or vomiting; 2, nausea without vomiting; 3, one episode of vomiting or persistent nausea; 4, two or more vomiting episodes within four hours. Higher scores indicate worse symptoms. Ondansetron use and total dose were also recorded.
Time frame: 0, 1, 3, 6, 12, 18 and 24 hours after Bromage score 0
Quality of recovery assessed by QoR-15
The Turkish Quality of Recovery-15 questionnaire was administered before and after surgery. Total scores range from 0 to 150, with higher scores indicating better recovery. The A section contains the first 10 positive items (0-100); the B section contains the last five negative symptom items (0-50), scored so that higher values mean fewer symptoms.
Time frame: Preoperatively on the morning of surgery and 24 hours after Bromage score 0
Time to first assisted standing
Time in hours from Bromage score 0 until the participant first stood with assistance. Follow-up continued to the first event even when it occurred after 24 hours.
Time frame: From complete resolution of spinal motor block (Bromage score 0) until first assisted standing during postoperative inpatient follow-up, an average of approximately 26 hours among assessed participants.
Time to first oral intake
Time in hours from complete resolution of spinal motor block (Bromage score 0) to first oral intake during the following 24 hours.
Time frame: First 24 hours after complete resolution of spinal motor block (Bromage score 0)
First passage of flatus or stool
Time in hours from complete resolution of spinal motor block (Bromage score 0) to whichever occurred first: passage of flatus or stool, during the following 24 hours. Participants without an event were observed for the full 24-hour period and classified as having no event within 24 hours. Event times were not assigned a zero duration.
Time frame: First 24 hours after complete resolution of spinal motor block (Bromage score 0)
Patient satisfaction
At 24 hours after complete resolution of spinal motor block (Bromage score 0), participants rated satisfaction with the treatment from 1 to 10. Higher scores indicate greater satisfaction.
Time frame: 24 hours after complete resolution of spinal motor block (Bromage score 0)
Plan to share: No — Our regulations forbid to share the IPD
No publications or documents are linked to this record.
Ran from May 2026 to primary completion in Sep 2026, 4 months.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 4 months is below that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 30, 2026: start Oct 2025 → May 2026, primary completion Apr 2026 → Sep 2026 and completion Jun 2026 → Sep 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hitit University